Atypical Antipsychotics, Elderly Patients, and Mortality Risk
- 1 October 2007
- journal article
- research article
- Published by Southern Medical Association in Southern Medical Journal
- Vol. 100 (10), 964-965
- https://doi.org/10.1097/smj.0b013e31815401cb
Abstract
Clinicians faced with the management of disturbed behavior in patients with dementia have a limited array of options. The risk of doing nothing will place the agitated patient at risk for harm to self or others, not to mention the discomfort of this often-dysphoric state. Second-generation, or atypical, antipsychotics such as olanzapine and risperidone can successfully reduce aggression and/or...Keywords
This publication has 8 references indexed in Scilit:
- Show Me the Evidence: Using Number Needed to TreatSouthern Medical Journal, 2007
- Antipsychotic Drug Use and Mortality in Older Adults with DementiaAnnals of Internal Medicine, 2007
- Neither Atypical Nor Conventional Antipsychotics Increase Mortality or Hospital Admissions Among Elderly Patients With Dementia: A Two-Year Prospective StudyAmerican Journal of Geriatric Psychiatry, 2007
- Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patientsCMAJ : Canadian Medical Association Journal, 2007
- Risk of Death in Elderly Users of Conventional vs. Atypical Antipsychotic MedicationsNew England Journal of Medicine, 2005
- Risk of Death With Atypical Antipsychotic Drug Treatment for DementiaJAMA, 2005
- Confidence intervals for the number needed to treatBMJ, 1998
- The mortality of delirium: An underappreciated problem?Psychosomatics, 1982